Pharmaceutical Fluid Handling Market Share Report ($14.20 Billion by 2028) Lead by United States (4.8% CAGR) – Comprehensive Report by The Insight Partners

The global pharmaceutical fluid handling market size is driven by increase in vaccine production, surge in drug production and rise in adoption of single-use systems (SUS) in pharmaceutical industry.


New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Pharmaceutical Fluid Handling Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Offering (Equipment & Solutions and Services), Tubing (Thermoplastic Elastomers, Polyvinyl Chloride, and Silicone), Application (Fluid Handling & Management, Fluid Preparation, Integration & Automation, Buffer Management, and Others), Usage (Cough Syrup, Intravenous Product, Complex Active Pharmaceutical Ingredients, and Others), and End User (Biotechnology Companies, Pharmaceutical & Medical Companies, and Others)”; the global pharmaceutical fluid handling market share is projected to reach USD 14.20 billion by 2028 from USD 10.30 billion in 2021; it is estimated to register a CAGR of 4.7% from 2022 to 2028.


Download PDF Brochure at https://www.theinsightpartners.com/sample/TIPRE00029767


Global Pharmaceutical Fluid Handling Market – Report Scope:

Market Size Value in USD 10.30 Billion in 2021
Market Size Value by USD 14.20 Billion by 2028
Growth rate CAGR of 4.7% from 2022 to 2028
Forecast Period 2022-2028
Base Year 2021
No. of Pages 278
No. of Tables 219
No. of Charts & Figures 94
Historical data available Yes
Segments covered Offering, Tubing, Application, Usage, and End User


Global Pharmaceutical Fluid Handling Market: Competitive Landscape and Key Developments

In Aug. 2022, Rigaku Corporation has acquired all issued shares of MILabs B.V.  on August 2, 2021, as part of their full-scale effort to enter the life sciences business. Through this acquisition, Rigaku will expand its life sciences modality business globally by combining MILabs’ multi-modality businesses, including PET, SPECT, Optical Imaging, and CT equipment for animals, with Rigaku's original X-ray imaging business for animals.

In Oct. 2022, Merck, a leading science and technology company, has opened a commercial facility for its new Millipore CTDMO Services offering at the company’s site in Martillac, France.


Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00029767


In Apr. 2022, Merck, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the Life Science business sector’s signing of an agreement with the Administrative Management Committee of Wuxi National High-Tech Industrial Development Zone to significantly expand the company’s first Asia Pacific Mobius Single-Use manufacturing center in China.

In Aug. 2022, Watson-Marlow Fluid Technology Solutions (WMFTS) has launched BioPure Braided Hose assemblies as an end-to-end solution for companies requiring fitting, hose, assembly and testing.

In Jul. 2022, A&G AS, based in the Estonian capital of Tallinn, has been part of the Raumedic group of companies since 2021. The company specializes in assembly in the field of medical technology and is equipped with corresponding cleanroom production space.

In Nov. 2021, Watson-Marlow Fluid Technology Solutions has been named as the Most Innovative Pharma Fluid Management Solutions Provider 2021 at the Global Health and Pharma (GHP) Healthcare and Pharmaceutical Awards. Watson-Marlow is specialized in peristaltic pumping technology and single-use Accusil silicone tubing and asepticsu tube assemblies. it is an ideal technology for the pharmaceutical industry as it provides precise flow rates with low shear and reduces contamination risk as the fluid is contained within the tube, never coming into contact with the pump mechanism.

In Sept. 2021, Watson-Marlow launched bioprocessing production at new Cork facility.  The ISO 14644-1 Class 7 cleanroom is fully certified to meet the demands of the highly regulated pharmaceutical and biopharmaceutical manufacturing offering a high quality and reliable supply for the growing Irish market.


Speak to Research Expert: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00029767


Impact of COVID-19 Pandemic on Global Pharmaceutical Fluid Handling Market Growth:

The COVID-19 pandemic disrupted everyday lives of people and businesses worldwide, and the pharmaceutical supply chain was greatly affected. The COVID-19 pandemic inflicted enormous pressure on healthcare infrastructure and hampered the operational capabilities of the biopharmaceutical companies and clinical laboratories. The COVID-19 pandemic led to a significant increase in industry growth, as pharmaceutical liquid handling was in high demand, as specimens had to be processed faster in the laboratory to conduct research on SAR-CoV-2. The COVID-19 vaccine development boosted the need for advanced automated liquid handling systems. As a result of the outbreak of COVID-19, the market has grown positively.

Pharmaceutical Fluid Handling Market: Segmental Overview

Based on tubing, the global pharmaceutical fluid handling market is segmented into thermoplastic elastomers (TPE), polyvinyl chloride (PVC), and silicone. In 2022, the silicone segment held the largest share of the market. The TPE segment is expected to grow at the highest CAGR during 2022–2028.

Based on end user, the pharmaceutical fluid handling market is segmented into biotechnology companies, pharmaceutical & medical companies, and others. The biotechnology companies segment held the largest market share in 2021, and it is further expected to be the largest shareholder in the market by 2028.


Buy Premium Copy of Pharmaceutical Fluid Handling Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00029767



Browse other research published by The Insight Partners:

Mid-Size Pharmaceutical Market - The global mid-size pharmaceutical market size is expected to grow from US$ 690,105.2 million in 2022 to US$ 1,000,584.3 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2028.

Branded Generics Market - The global branded generics market size is expected to grow from US$ 235.86 billion in 2022 to US$ 414.99 billion by 2028; it is estimated to grow at a CAGR of 9.9% from 2022 to 2028.

Precision Diagnostics Market - The global precision diagnostics market size is projected to reach US$ 168,405.71 million by 2028 from US$ 79,776.88 million in 2022; it is expected to grow at a CAGR of 13.3% from 2022 to 2028.

Amniotic Products Market - The global amniotic products market size is expected to grow from US$ 1,164.32 million in 2022 to US$ 1,889.07 million by 2028. It is estimated to grow at a CAGR of 8.4% from 2022 to 2028.

Human Papillomavirus (HPV) Vaccine Market - The global human papillomavirus (HPV) vaccine market size was valued at US$ 4,273.84 million in 2022 and is projected to reach US$ 5,730.50 million by 2028; it is expected to grow at a CAGR of 5.0% from 2022 to 2028.

Genotyping Market - The global genotyping market size is expected to grow from US$ 79,407.14 million in 2028 from US$ 25,191.28 million in 2022; it is estimated to grow at a CAGR of 20.1% during 2022–2028.

Anti-Infective Agents Market - The global anti-infective agents market size is expected to grow from US$ 1,35,961.03 million in 2022 to US$ 1,64,196.61 million by 2028; it is estimated to grow at a CAGR of 3.19% from 2022 to 2028.

Doxorubicin Market - The global doxorubicin market size is projected to reach US$ 1,983.40 million by 2028 from US$ 1,390.64 million in 2022. It is expected to register a CAGR of 6.1% from 2022 to 2028.

Pharma ADMET Testing Market - The global pharma ADMET testing market size is expected to grow from US$ 6,783.06 million in 2021 to US$ 13,578.62 million by 2028; it is estimated to grow at a CAGR of 10.5% from 2022 to 2028.

Sports Nutrition Market - The global sports nutrition market size is expected to grow from US$ 41,683.48 million in 2021 to US$ 72,178.19 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.



About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/pharmaceutical-fluid-handling-market